Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects

Clinical trial NCT02151409 · COMPLETED

Trial details

NCT number: NCT02151409
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Inflammation Systemic Lupus Erythematosus Rheumatoid Arthritis Healthy

Start date: 2008-06-01
Primary completion: 2009-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.